tldrdailynews.com logo
Tag

Cvs Health

All articles tagged with #cvs health

CVS to Pay $315 Million to Resolve Federal Opioid Litigation
business1 hour ago

CVS to Pay $315 Million to Resolve Federal Opioid Litigation

CVS Health has agreed to pay $315 million to settle a case brought by the US Department of Justice regarding its role in the opioid crisis. The agreement resolves federal allegations related to the pharmacy chain's distribution and marketing practices for opioid medications. This financial resolution marks a significant development in ongoing legal efforts to hold major healthcare providers accountable for contributing to the national overdose epidemic.

via AP News|
#business#cvs-health#healthcare
Returning Home to Family as H-1B Hurdles Push a Data Scientist Back to India
business1 month ago

Returning Home to Family as H-1B Hurdles Push a Data Scientist Back to India

Disha Lamba, a 28-year-old data scientist who studied at NYU and worked at CVS Health on an H-1B visa, moved from the U.S. to Gurugram, India in May 2026 to be near family and escape the visa limitations and stamping hassles. After thriving in New York and earning a six-figure salary, she resigned, took two months off to reassess, and is exploring opportunities in India where she can switch employers or start a startup without H-1B constraints, while balancing homesickness for the U.S. with the daily support of family and new career flexibility.

via Business Insider|
#business#cvs-health#data-science
CVS Reinstates Zepbound Coverage and Adds Lilly’s Foundayo Obesity Pill
health4 months ago

CVS Reinstates Zepbound Coverage and Adds Lilly’s Foundayo Obesity Pill

CVS Caremark will restore Eli Lilly’s obesity drug Zepbound to its commercial formularies on October 1 and add Lilly’s obesity pill Foundayo as a co‑preferred option, aiming to provide equal access and copays with Novo Nordisk’s Wegovy (as low as $25 a month for eligible commercially insured patients). All three of the nation’s largest pharmacy benefit managers now cover Lilly’s obesity portfolio, a move that could boost Foundayo sales in the second half of the year as employers and health plans seek more affordable GLP‑1 weight‑loss options.

via Reuters|
#cvs-health#foundayo#health
CVS Health Beats Q1, Uplifts 2026 Guidance on Aetna Momentum
business5 months ago

CVS Health Beats Q1, Uplifts 2026 Guidance on Aetna Momentum

CVS Health beat Q1 estimates across all segments, delivering adjusted earnings of $2.57 per share on $100.43 billion in revenue and raising full-year guidance to $7.30–$7.50 per share and at least $405 billion in revenue, driven by improving performance in Aetna and ongoing cost cuts, store closures, and leadership changes as part of its turnaround; shares rose in premarket trading.

via CNBC|
#aetna#business#cvs-health
CVS Health sticks to 2026 targets after robust Q4 beat
business8 months ago

CVS Health sticks to 2026 targets after robust Q4 beat

CVS Health beat Q4 estimates with adjusted EPS of $1.09 and revenue of $105.69 billion, and reaffirmed its 2026 guidance of $7.00–$7.20 per share and at least $400 billion in revenue. Management cited headwinds from exiting ACA exchanges and lower drug prices under new pricing deals, while growth is expected from Caremark and improving Aetna margins, Oak Street Health, and the Rite Aid prescription integration.

via CNBC|
#2026-guidance#business#caremark
politics8 months ago

House Grills Health-Insurer CEOs on Sky-High Pay Amid Rising Costs

During a House hearing on health-care affordability, lawmakers pressed five health-insurer CEOs about why pay remains high as customers struggle; CVS Health's David Joyner explained his 2024 compensation was about $17 million (roughly $1.1 million base plus long-term incentives) and said he returned a bonus to a relief fund, while Democrats argued stock options and bonuses can incentivize prioritizing shareholders over patients.

via Politico|
#affordability#congress#cvs-health
CVS Surges on Strong Q2 Earnings and Improved Outlook
business1 year ago

CVS Surges on Strong Q2 Earnings and Improved Outlook

CVS Health reported an 8.4% increase in Q2 2025 revenues to $98.9 billion, with adjusted EPS of $1.81, and revised full-year guidance to reflect strong performance in healthcare benefits and pharmacy segments, despite some declines in health services. The company emphasizes its focus on providing a connected, simpler healthcare experience and continues to execute strategic initiatives to create long-term value.

via CVS Health|
#2025-results#business#cvs-health
CVS Health Faces Challenges Amid Industry Crisis and Potential Earnings Hit
finance1 year ago

CVS Health Faces Challenges Amid Industry Crisis and Potential Earnings Hit

Shares of CVS Health Corporation are trading lower, potentially breaking a crucial support level at $52.50, which has held since 2019. This break could signal the start of a new downtrend as sellers dominate the market. The concept of 'market memory' suggests that this level has been significant for years, and its breach may lead to further price declines.

via Benzinga|
#cvs-health#downtrend#finance
CVS Health Shakes Up Leadership Amid Mixed Q3 Results and Stock Fluctuations
business1 year ago

CVS Health Shakes Up Leadership Amid Mixed Q3 Results and Stock Fluctuations

CVS Health has appointed new leadership under CEO David Joyner, including Steve Nelson from UnitedHealth to lead its struggling Aetna insurance division, as part of efforts to revive the company's performance. Despite a 6.3% rise in revenue to $95.43 billion, CVS reported a 96% drop in third-quarter profit due to restructuring charges, missing earnings expectations. The company faces challenges from rising Medicare Advantage claims and Medicaid pressures, prompting criticism from shareholders and a need for strategic improvements.

via Yahoo Finance|
#aetna#business#ceo